Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study. - Weiß C; Becker LL; Friese J; Blaschek A; Hahn A; Illsinger S; Schwartz O; Bernert G; Hagen MV; Husain RA; Goldhahn K; Kirschner J; et al. (The Lancet regional health. Europe, 2024)